Lactose (India) Ltd Share Price – BSE

Pharmaceuticals, Small Cap

Lactose (India) will hold a meeting of the Board of Directors of the Company on 18 June 2026.

Net profit of Lactose (India) rose 193.75% to Rs 1.88 crore in the quarter ended March 2026 as against Rs 0.64 crore during the previous quarter ended March 2025. Sales rose 64.82% to Rs 45.77 crore in the quarter ended March 2026 as against Rs 27.77 crore during the previous quarter ended March 2025.

For the full year,net profit rose 17.44% to Rs 6.06 crore in the year ended March 2026 as against Rs 5.16 crore during the previous year ended March 2025. Sales rose 40.28% to Rs 163.29 crore in the year ended March 2026 as against Rs 116.40 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Revenue from operations soared 64.81% year-on-year to Rs 45.77 crore in the quarter ended 31 March 2026.

Total expenses increased 58.28% year-on-year to Rs 43.67 crore during the quarter, compared with Rs 27.59 crore in the year-ago period. The cost of materials consumed stood at Rs 28.28 crore, up 59.23% YoY, while employee benefits expenses rose 5.37% to Rs 3.53 crore.

Profit before tax (PBT) stood at Rs 2.31 crore in Q4 FY26, registering a growth of 320% from Rs 0.55 crore reported in Q4 FY25.

For the full financial year FY26, the company posted a 17.44% rise in consolidated net profit to Rs 6.06 crore, while revenue rose 40.28% to Rs 163.29 crore compared with FY25.

Lactose (India) is a pharmaceutical company engaged in the business of manufacturing, trading and carrying out job work and manufacturing of pharmaceutical products.

Powered by Capital Market - Live News

Lactose (India) will hold a meeting of the Board of Directors of the Company on 20 May 2026.